@jennifer-carroll Ah, that makes sense! So, if the DTCI campaign did not include ANY mention of disease management (the CTA would be something like "talk to your doctor if you've experienced any of these symptoms"), does that change your answer? In that case, could the creative be the same for both audiences?
C
copycallosum
@copycallosum
The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB),
including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB
correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system.
Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly
prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.
Posts
-
Visual connection between DTCI and unbranded HCP-facing DSE -
Visual connection between DTCI and unbranded HCP-facing DSEI'm wondering if it would be considered compliant to use the same creative concept (visuals/look/feel) in a disease state awareness campaign in the DTC space as in the HCP space. For added context, the DTCI campaign will likely include a broad and balanced discussion of treatment options and a CTA to talk to your doctor; it will go through ASC review. The HCP campaign will be disease state education only with no mention of treatment/management; it will go to PAAB to confirm exemption status. Can these two campaigns contain similar creative elements?